These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

842 related items for PubMed ID: 9063493

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [Abstract] [Full Text] [Related]

  • 23. Cytokines in the differentiation of Th1/Th2 CD4+ subsets in leishmaniasis.
    Reiner SL, Locksley RM.
    J Cell Biochem; 1993 Dec; 53(4):323-8. PubMed ID: 7905485
    [Abstract] [Full Text] [Related]

  • 24. Some of the early events underlying Th2 cell maturation and susceptibility to Leishmania major infection in BALB/c mice.
    Himmelrich H, Launois P, Tacchini-Cottier F, Louis JA.
    Biol Chem; 1999 Dec; 380(7-8):909-14. PubMed ID: 10494841
    [Abstract] [Full Text] [Related]

  • 25. The effector mechanism and vaccination against cutaneous leishmaniasis.
    Liew FY.
    Behring Inst Mitt; 1991 Feb; (88):239-43. PubMed ID: 2049044
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR.
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL, Antúnez MI, Abrami AA.
    Medicina (B Aires); 1999 Oct; 59 Suppl 2():84-90. PubMed ID: 10668248
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 33. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.
    Sjölander A, Baldwin TM, Curtis JM, Handman E.
    J Immunol; 1998 Apr 15; 160(8):3949-57. PubMed ID: 9558102
    [Abstract] [Full Text] [Related]

  • 34. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M, Akagawa K, Kobayashi K, Sugawara I, Kawakami K, Yamamoto S, Okada Z.
    Kekkaku; 2003 Jan 15; 78(1):51-5. PubMed ID: 12683337
    [Abstract] [Full Text] [Related]

  • 35. Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma.
    Miner KT, Croft M.
    J Immunol; 1998 Jun 01; 160(11):5280-7. PubMed ID: 9605125
    [Abstract] [Full Text] [Related]

  • 36. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V.
    Hum Immunol; 2009 Jun 01; 70(6):383-90. PubMed ID: 19480861
    [Abstract] [Full Text] [Related]

  • 37. Th1/Th2 cross regulation.
    Fishman MA, Perelson AS.
    J Theor Biol; 1994 Sep 07; 170(1):25-56. PubMed ID: 7967633
    [Abstract] [Full Text] [Related]

  • 38. Peritoneal T cell responses can be polarized toward Th1 or Th2 in children on chronic peritoneal dialysis.
    Chiesa S, Vigo G, Cappa F, Prigione I, Pistoia V, Verrina E, Perfumo F, Barbano G.
    Artif Organs; 2004 Aug 07; 28(8):750-2. PubMed ID: 15270959
    [Abstract] [Full Text] [Related]

  • 39. Soluble IL-4 receptor, potential for therapeutic and prophylactic intervention.
    Gessner A, Röllinghoff M.
    Behring Inst Mitt; 1994 Dec 07; (95):35-41. PubMed ID: 7755507
    [Abstract] [Full Text] [Related]

  • 40. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK, Gupta R, Sundar S, Sahasrabuddhe AA, Dube A.
    J Immunol; 2011 Dec 15; 187(12):6417-27. PubMed ID: 22079980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.